EURONEXT:ABNX
ABIONYX Pharma SA
- Stock
Last Close
1.28
30/08 15:14
Market Cap
39.38M
Beta: 0.27
Volume Today
6.31K
Avg: 123.73K
PE Ratio
−7.77
PFCF: −10.89
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 88.50K - | 162K 83.05% | ||||||||||
average payables | 3.42M - | 4.67M 36.71% | 5.24M 12.27% | 3.97M 24.31% | 2.32M 41.55% | 1.69M 27.27% | 1.83M 8.71% | 2.56M 39.48% | 2.28M 10.91% | |||
average receivables | ||||||||||||
book value per share | 0.47 - | 0.00 99.81% | 2.00 218,830.90% | 0.82 59.13% | 0.49 40.32% | 0.21 57.60% | 0.32 56.74% | 0.29 8.99% | 0.43 45.71% | 0.26 40.27% | ||
capex per share | -0.00 - | -0.00 62.50% | -0.01 4,410.64% | -0.00 97.28% | -0.01 4,079.28% | -0.00 89.39% | -0.01 - | -0.01 1.47% | -0.01 6.22% | |||
capex to depreciation | -0.05 - | -0.03 33.52% | -3.05 8,857.14% | -0.10 96.59% | -4.95 4,655.35% | -0.59 88.09% | -6.73 - | -1.39 79.26% | -1.30 7.07% | |||
capex to operating cash flow | 0.00 - | 0.00 64.54% | 0.01 1,273.14% | 0.00 97.91% | 0.02 8,894.63% | 0.00 83.64% | 0.25 - | 0.02 89.96% | 0.05 110.03% | |||
capex to revenue | -0.13 - | -0.25 - | -0.03 86.45% | |||||||||
cash per share | 0.85 - | 0.60 29.60% | 2.58 333.37% | 1.38 46.64% | 0.89 35.30% | 0.62 30.84% | 0.40 34.40% | 0.41 0.56% | 0.32 21.58% | 0.14 54.64% | ||
days of inventory on hand | 155.30 - | 11.62 92.52% | ||||||||||
days payables outstanding | 2.37K - | 146.52 93.83% | ||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.29 - | 0.46 58.46% | 0.13 71.31% | 0.24 83.65% | 0.34 40.12% | 0.42 23.18% | 0.12 72.45% | 0.00 97.98% | 0.23 9,634.93% | 0.25 11.68% | ||
debt to equity | 0.66 - | 416 63,224.90% | 0.18 99.96% | 0.48 163.07% | 0.70 44.99% | 1.43 104.84% | 0.18 87.63% | 0.00 97.96% | 0.46 12,726.08% | 0.56 20.55% | ||
dividend yield | ||||||||||||
earnings yield | -0.05 - | -0.04 15.23% | -0.08 94.46% | -0.16 104.16% | -0.14 11.90% | -0.69 389.48% | 0.27 138.47% | -0.08 131.81% | -0.10 13.12% | -0.09 6.77% | ||
enterprise value | 155.19M - | 159.43M 2.73% | 174.71M 9.58% | 136.98M 21.59% | 25.14M 81.64% | 3.15M 87.46% | -206.11K 106.54% | 13.13M 6,470.63% | 57.85M 340.60% | 48.13M 16.81% | ||
enterprise value over ebitda | -21.16 - | -29.90 41.28% | -11.37 61.97% | -5.81 48.89% | -5.28 9.22% | -0.57 89.23% | -0.09 83.88% | -7.04 7,593.29% | -10.16 44.21% | -12.00 18.14% | ||
ev to operating cash flow | -10.71 - | -48.27 350.78% | -12.74 73.60% | -7.14 44.00% | -2.77 61.24% | -0.53 81.00% | 0.05 109.93% | -21.92 42,110.03% | -8.65 60.56% | -14.33 65.73% | ||
ev to sales | 18.12 - | 85.71 - | 9.16 89.31% | |||||||||
free cash flow per share | -1.10 - | -0.25 77.20% | -0.83 232.29% | -1.07 28.47% | -0.51 52.46% | -0.32 36.41% | -0.19 40.84% | -0.03 82.69% | -0.28 730.56% | -0.13 54.16% | ||
free cash flow yield | -0.09 - | -0.02 77.20% | -0.07 222.10% | -0.12 88.92% | -0.26 113.29% | -0.66 150.19% | -0.57 13.98% | -0.03 94.10% | -0.11 235.96% | -0.07 34.91% | ||
graham net net | 0.26 - | -0.23 188.28% | 1.81 897.26% | 0.57 68.41% | 0.38 34.12% | 0.12 69.10% | 0.23 98.41% | 0.24 5.92% | -0.13 151.56% | -0.16 28.82% | ||
graham number | 2.49 - | 0.10 95.94% | 6.70 6,527.27% | 5.05 24.67% | 1.73 65.77% | 1.26 27.37% | 0.81 35.60% | 0.75 7.83% | 1.50 101.86% | 0.94 37.37% | ||
income quality | 1.87 - | 0.50 73.12% | 0.82 63.74% | 0.77 6.34% | 1.83 136.63% | 0.95 47.89% | -2.14 324.45% | 0.32 114.87% | 1.15 261.91% | 0.80 30.52% | ||
intangibles to total assets | 0.00 - | 0 100% | 0.00 Infinity% | 0.00 0.85% | 0.01 6,698.83% | 0.02 38.65% | 0 100% | 0.00 Infinity% | 0.25 5,612.41% | 0.34 37.90% | 0 100% | |
interest coverage | -46.70 - | -6.61 85.84% | -12.71 92.33% | -19.12 50.38% | -39.74 107.85% | 6.39 - | -744 - | -67.36 90.95% | -11.67 82.68% | |||
interest debt per share | 0.32 - | 0.45 38.80% | 0.44 2.11% | 0.46 5.59% | 0.35 24.58% | 0.30 15.42% | 0.07 74.87% | 0.00 98.57% | 0.20 18,619.33% | 0.15 27.02% | ||
inventory turnover | 2.35 - | 31.40 1,236.07% | ||||||||||
invested capital | 0.66 - | 416 63,224.90% | 0.18 99.96% | 0.48 163.07% | 0.70 44.99% | 1.43 104.84% | 0.18 87.63% | 0.00 97.96% | 0.46 12,726.08% | 0.56 20.55% | ||
market cap | 162.28M - | 162.28M 0% | 211.56M 30.36% | 154.90M 26.78% | 35.19M 77.28% | 9.11M 74.12% | 6.94M 23.77% | 22.26M 220.67% | 60.83M 173.27% | 48.16M 20.83% | ||
net current asset value | 6.00M - | -61K 101.02% | 32.75M 53,793.44% | 14.27M 56.44% | 8.46M 40.71% | 3.49M 58.79% | 6.54M 87.66% | 6.37M 2.58% | 1.86M 70.88% | -1.08M 158.30% | ||
net debt to ebitda | 0.97 - | 0.53 44.72% | 2.40 348.71% | 0.76 68.31% | 2.11 177.34% | 1.07 49.11% | -3.18 395.95% | 4.90 254.25% | 0.52 89.33% | 0.01 98.43% | ||
net income per share | -0.59 - | -0.50 15.23% | -1.00 100.61% | -1.39 38.84% | -0.27 80.36% | -0.34 24.40% | 0.09 126.46% | -0.08 193.35% | -0.23 179.65% | -0.15 34.34% | ||
operating cash flow per share | -1.10 - | -0.25 77.21% | -0.82 228.49% | -1.07 30.04% | -0.50 53.54% | -0.32 35.17% | -0.19 40.61% | -0.03 86.12% | -0.27 910.70% | -0.12 55.35% | ||
payables turnover | 0.15 - | 2.49 1,519.81% | ||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 24.68 - | 7.30 - | 0.21 97.11% | 0.33 54.71% | ||||||||
return on tangible assets | -0.56 - | -0.61 8.92% | -0.36 40.40% | -0.86 137.13% | -0.28 67.83% | -0.49 77.24% | 0.18 136.97% | -0.18 202.06% | -0.36 93.34% | -0.41 16.55% | ||
revenue per share | 0.01 - | 0.03 - | 0.19 592.19% | |||||||||
roe | -1.26 - | -546.92 43,430.10% | -0.50 99.91% | -1.70 239.68% | -0.56 67.10% | -1.64 193.39% | 0.28 116.88% | -0.28 202.57% | -0.55 91.92% | -0.60 9.92% | ||
roic | -0.97 - | -1.21 24.87% | -0.40 67.24% | -1.11 180.76% | -0.44 60.39% | -0.76 71.86% | 0.28 136.61% | -0.44 260.78% | -0.33 26.68% | -0.32 2.94% | ||
sales general and administrative to revenue | 6.84 - | 0.87 - | 0.25 71.03% | |||||||||
shareholders equity per share | 0.47 - | 0.00 99.81% | 2.00 218,830.90% | 0.82 59.13% | 0.49 40.32% | 0.21 57.60% | 0.32 56.74% | 0.29 8.99% | 0.43 45.71% | 0.26 40.27% | ||
stock based compensation to revenue | 0.19 - | 0.10 - | ||||||||||
tangible asset value | 6.16M - | 12K 99.81% | 33.19M 276,491.67% | 14.61M 56.00% | 8.67M 40.61% | 3.62M 58.22% | 6.67M 83.94% | 6.58M 1.23% | 5.22M 20.69% | 1.72M 67.12% | ||
tangible book value per share | 0.47 - | 0.00 99.81% | 2.00 218,778.15% | 0.82 59.12% | 0.49 40.32% | 0.19 59.95% | 0.32 65.95% | 0.29 9.61% | 0.21 28.25% | 0.06 70.75% | ||
working capital | 10.68M - | 6.06M 43.23% | 39.87M 557.61% | 22.03M 44.75% | 14.63M 33.58% | 4.27M 70.79% | 6.66M 55.84% | 6.43M 3.38% | 6.26M 2.64% | 2.48M 60.44% |
All numbers in EUR (except ratios and percentages)